secwatch.observer — SEC 8-K summary
======================================

Issuer:     ANI PHARMACEUTICALS INC (ANIP)
CIK:        0001023024
Form:       8-K
Filed at:   2026-04-07T23:59:59+00:00
Accession:  0001023024-26-000034
Event type: other_material
Sentiment:  neutral
Materiality: 0.55
Item codes: 4.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

ANI Pharmaceuticals dismisses EisnerAmper, appoints Ernst & Young as auditor
----------------------------------------------------------------------------

- EisnerAmper dismissed as independent auditor effective April 1, 2026; Audit Committee approved.
- EisnerAmper reports for FY 2025 and 2024 had no adverse opinion or qualification.
- No disagreements or reportable events during fiscal years 2025, 2024, and through dismissal.
- Ernst & Young (EY) appointed as new independent auditor for fiscal year 2026, effective April 1, 2026.
- No prior consultations with EY regarding accounting matters under Regulation S-K Item 304.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1023024/000102302426000034/0001023024-26-000034-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1023024/000102302426000034/ani-20260401.htm
  HTML page:      https://secwatch.observer/filing/0001023024-26-000034

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer